TESTS PG

VOL. 122, ISSUE NO. 38

GET IN TOUCH

EMERALD MEDIA GROUP 1395 UNIVERSITY ST., #302 EUGENE, OR 97403 541.346.5511

NEWSROOM

EDITOR IN CHIEF Ryan Nguyen

MANAGING EDITOR Francis O’Leary

ENGAGEMENT EDITOR Ashley Ng

NEWS EDITORS Jack Forrest Duncan Baumgarten Ardeshir Tabrizian

A&C EDITORS Sarah-Mae McCullough Grace Murray

SPORTS EDITORS Shane Hoffmann Mojo Hill Charlie Gearing

PHOTO EDITOR Maddie Knight

DESIGN EDITOR Kira Chan

COPY CHIEF Sophia Edelblute Capps

MULTIMEDIA EDITORS Meaghan FitzPatrick Sarah Miller

DIGITAL EDITOR Jordan McMinn

BUSINESS

PUBLISHER & PRESIDENT Bill Kunerth X317

bkunerth@dailyemerald.com

VP OPERATIONS

Kathy Carbone X302 kcarbone@dailyemerald.com

DIRECTOR OF SALES & DIGITAL MARKETING

Shelly Rondestvedt X303 srondestvedt@dailyemerald.com

CREATIVE & TECHNICAL DIRECTOR

Sam Rudkin X327

creative@dailyemerald.com

STUDENT SALES MANAGER Stella Kalomiris

ACCOUNT EXECUTIVES Patrick McCumber Keaton Roberts Amy Menendez

THE DAILY EMERALD

The Daily Emerald is published by Emerald Media Group, Inc., the independent nonprofit media company at the University of Oregon. Formerly the Oregon Daily Emerald, the news organization was founded in 1900.

ON THE COVER

Steam is produced at UO Central Power Station in order to heat the University’s campus through a direct heating system. The UO Central Power Station is responsible for providing energy to the University of Oregon. (Ian Enger/Emerald)

UO WAITING FOR APPROVAL OF SALIVA COVID-19 TESTS

SALIVA TESTING AT UO HAS BEEN IN THE WORKS SINCE THE SUMMER BUT HAS NOT BEEN IMPLEMENTED YET.

BY SILAS SLOAN • TWITTER @SILASLOAN

(Kendal/Unsplash)

The University of Oregon announced in June 2020 that it would be applying for emergency use authorization of a saliva-based COVID-19 test. While approved, it is yet to be implemented.

The executive director of UO’s Monitoring and Assessment Program, Brian Fox, said that the university began to develop a lab that could process nasal swab and saliva testing last year. UO decided to primarily use nasal swabs since they were approved before saliva testing, and the community became more comfortable with them, Fox said.

“We felt like we could go a little bit slower on developing the other one, like it wasn’t worth doing a lab-developed test,” he said. “The research process for that can take a while, and we had something that worked.”

SalivaDirect — the method UO would use — was developed by the Yale School of Public Health. According to Yale’s SalivaDirect website, the method detects the virus in a similar way but is cheaper. Fox said it’s also as accurate as nasal swabs.

The FDA issued emergency use authorization for SalivaDirect in August 2020. Even though the MAP website says it has been approved, UO has yet to make use of it.

Fox said that UO is making modifications to the original testing method and is currently waiting for FDA approval for those updates, which is delaying the rollout. The August emergency use authorization issued for the original method “involved a process that was not designated to work with the automation that UO has in place in our lab,” he said.

“We have been working with Yale to propose and submit modifications to the SalivaDirect EUA to the FDA, which if approved would allow us to do automated saliva testing under their EUA,” Fox said.

The rollout of saliva testing is looking like it may be coming soon. Fox said the University of Illinois has made progress in optimizing the process, and UO is waiting to see whether it could work.

“We’d love to move quickly. But I think it’ll be kind of a slow, measured piece because we want to get it right,” he said.

Adding an additional testing method has many benefits. Not only is saliva testing as accurate, cheaper and faster than nasal swabs, Fox said that the university will be able to test on a larger scale.

“The real benefit for us is that that efficiency gain in the lab means that our overall capacity would increase,” he said. “Which means that we can support the state and the community and other partners in their testing needs.”

Fox said he is proud of the way the MAP team has been dealing with the challenge of COVID-19 testing and is excited about saliva testing.

“I think it’s one more way that they can lead the charge right in partnering with leading institutions across the country to figure out how to do something new,” he said. “Really taking science into the community and applying it is such a great application of our mission.”

Around OR

REGIONAL AND STATE NEWS

NEW COVID-19 VARIANT

FOUND IN OREGON: Following a COVID-19 outbreak in Marion County, OHSU scientists found a variant with lineage connecting it to the UK and South African variants, OPB reported. Scientists are advising Oregonians to wear masks, keep their distance from others and big groups and get vaccinated as soon as possible to reduce the risk of contracting the variant. – KATHERINE WINELAND

NO. 5 OREGON SOFTBALL

CONTINUE HOT START: After defeating Oregon State 14-6 on Saturday, March 13, the Oregon softball team sits at 15-1 and has won six games in a row. After their game against Sacramento State on March 14, the Ducks will host Utah the following weekend. Haley Cruse leads the Ducks with 18 runs to go along with 13 RBIs. – SHANE HOFFMANN

CHALLENGING THE

TRADITIONS OF BALLET: On March 30, Oregon Ballet Theatre will host a virtual discussion called “(R)Evolve: Can Ballet Survive Its Traditions?” Panelists will discuss racism, sexism and other forms of oppression in the ballet industry. Speakers include writer Phil Chan, who co-founded a movement dedicated to eliminating offensive images of Asians in dance, along with body positive activist and former New York City Ballet soloist Kathryn Morgan and several members of OBT’s artistic staff. – JENNAH PENDLETON

(Ian Enger/Emerald)